Jenny Sundqvist new CEO of InDex Pharmaceuticals
October 10, 2022 – InDex Pharmaceuticals Holding AB (publ) today announced that the Board of Directors has named Jenny Sundqvist as new CEO. Jenny comes from a position as Chief Commercial Officer at Isofol Medical AB and has broad experience from leading positions within the pharmaceutical industry. Johan Giléus, who has been acting CEO since April 2022, will continue as CFO in the company.“We are very pleased to welcome Jenny Sundqvist as the new CEO of InDex Pharmaceuticals. Jenny's knowledge and experience in pharmaceutical development and business management will be of great benefit